Literature DB >> 3023203

Dose related in vitro effects of ranitidine and cimetidine on basal and ACTH-stimulated steroidogenesis.

C J Kenyon, R Fraser, G G Birnie, J M Connell, A F Lever.   

Abstract

Isolated bovine adrenocortical cells were incubated with and without 3 ng/ml ACTH, with various concentrations (10-1000 micrograms/ml) of either cimetidine or ranitidine. Cortisol, corticosterone, and deoxycorticosterone outputs were measured. Cimetidine and ranitidine at 320 and 1000 micrograms/ml inhibited ACTH-stimulated corticosterone and cortisol synthesis and cimetidine decreased basal cortisol synthesis. The inhibitory effects of cimetidine on cortisol synthesis were approximately 10 times greater than those of ranitidine. Cimetidine (1000 micrograms/ml), but not ranitidine increased deoxycorticosterone synthesis by ACTH-stimulated cells, indicating inhibition of 11 beta-hydroxylation in the adrenal steroidogenic pathway. Although doses of cimetidine and ranitidine which produce these in vitro effects are much greater than plasma concentrations in normal clinical use, they might be important in acutely ill patients given intravenous bolus injections of cimetidine, or if either antagonist were accumulated by the adrenal to produce high intracellular concentrations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023203      PMCID: PMC1433889          DOI: 10.1136/gut.27.10.1143

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  In vitro effects of ACTH, angiotensins, serotonin and potassium on steroid output and conversion of corticosterone to aldosterone by isolated adrenal cells.

Authors:  R Haning; S A Tait; J F Tait
Journal:  Endocrinology       Date:  1970-12       Impact factor: 4.736

2.  Inhibition by etomidate of steroidogenesis in isolated bovine adrenal cells.

Authors:  C J Kenyon; J Young; C E Gray; R Fraser
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

3.  Delayed clearance of diazepam due to cimetidine.

Authors:  U Klotz; I Reimann
Journal:  N Engl J Med       Date:  1980-05-01       Impact factor: 91.245

4.  The interaction of cimetidine with rat liver microsomes.

Authors:  P E Reilly; L E Carrington; D J Winzor
Journal:  Biochem Pharmacol       Date:  1983-03-01       Impact factor: 5.858

5.  Cimetidine and adrenals.

Authors:  G De Natale; M Vacca; P Preziosi
Journal:  Arzneimittelforschung       Date:  1980

6.  Interference by ranitidine with aldosterone secretion in vivo.

Authors:  J M Sancho; R Garcia Robles; E Mancheño; C Paya; J L Rodicio; L Ruilope
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Cimetidine: interaction with oral anticoagulants in man.

Authors:  M J Serlin; R G Sibeon; S Mossman; A M Breckenridge; J R Williams; J L Atwood; J M Willoughby
Journal:  Lancet       Date:  1979-08-18       Impact factor: 79.321

8.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20

9.  Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes.

Authors:  D S Loose; P B Kan; M A Hirst; R A Marcus; D Feldman
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Cimetidine impairs the elimination of theophylline and antipyrine.

Authors:  R K Roberts; J Grice; L Wood; V Petroff; C McGuffie
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

  10 in total
  10 in total

1.  Long-term intravenous cimetidine treatment does not alter cortisol response in hemodynamically stable intensive care unit patients.

Authors:  H Spapen; M Diltoer; N De Wit; L Duinslaeger; L Huyghens
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

Review 2.  Dosage regimen of cimetidine reviewed. Possible drug accumulation after multiple oral doses.

Authors:  J Prandota; I J Smith; J T Wilson
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 3.  Human cytochrome P450 enzymes 5-51 as targets of drugs and natural and environmental compounds: mechanisms, induction, and inhibition - toxic effects and benefits.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2018-08       Impact factor: 4.518

4.  In vivo and in vitro studies of the site of inhibitory action of omeprazole on adrenocortical steroidogenesis.

Authors:  L J Dowie; J E Smith; A J MacGilchrist; R Fraser; J W Honour; J L Reid; C J Kenyon
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Authors:  A Fitton; L Wiseman
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 6.  Side effects of ranitidine.

Authors:  T Vial; C Goubier; A Bergeret; F Cabrera; J C Evreux; J Descotes
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

7.  Ascorbic acid prevents cimetidine-induced decrease of serum hydrocortisone concentrations.

Authors:  M P Boidin; A Stuurman; W Erdmann
Journal:  Pharm Weekbl Sci       Date:  1990-08-24

Review 8.  Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Authors:  T Andersson
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

9.  The effects of omeprazole on endocrine function in man.

Authors:  A J MacGilchrist; C W Howden; C J Kenyon; G H Beastall; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Ranitidine treatment and cortisol metabolism in man.

Authors:  H Mönig; K Hoffmann; E E Ohnhaus; H M Schulte
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jan-Mar       Impact factor: 2.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.